Emergen Research has recently published a new report on the Global Cancer Imaging Systems market that offers key insights about the regional and global scope of the Cancer Imaging Systems market. It offers key details about the recent product launches, technological advancements, supply and demand ratio, and regulatory framework. The report also offers details about market size, market share, revenue growth, and CAGR during the forecast period of 2023-2032.

The global cancer imaging systems market is projected to be worth USD 12.24 Billion by 2027, according to a current analysis by Emergen Research. The cancer imaging systems market is observing high demand attributed to the increasing incidence of cancer. Cancer significantly impacts the societal and economic growth in the US and worldwide and is a major contributor to the cost burden of disease. It has been anticipated that 1,806,590 new cancer cases are likely to be diagnosed in the US in 2020, and 606,520 deaths will occur owing to the disease.

Growing technological advancements and increased investments in cancer imaging are causative of the rapid growth of the market. Hologic, Inc., in November 2019, received approval from the US Food and Drug Administration (FDA) for its 3DQuorum™ Imaging Technology, driven by Genius AI™. The technology works simultaneously with Hologic’s Clarity HD™ high-resolution imaging technology and helps radiologists reduce tomosynthesis image volume by 66.0%. The breast imaging system owing to such advancements would produce higher-resolution 3D images, better workflow, and an improved mammography experience for patents necessitating low radiation dose.

The report also offers key insights about top companies in the market along with a thorough SWOT analysis, Porter’s Five Forces analysis, and feasibility analysis to offer competitive edge to the readers. The report focuses on the recent trends, major challenges and opportunities, and limitations pertaining to the ongoing pandemic.

To know more about the report @ https://www.emergenresearch.com/industry-report/cancer-imaging-systems-market

The report also discusses the key players involved in the market such as GE Healthcare, Hitachi Medical, Becton, Dickinson, and Company, Thermo Fisher Scientific Inc., CR Bard Inc., Agilent Technologies, Abbott, Illumina Inc., Roche,, Philips Healthcare and others as well as new entrants in the market. It focuses on the recent mergers & acquisitions, joint ventures, collaborations, partnerships, licensing agreements, brand promotions, and product launches, among others. The report also provides details about the company overview, business expansion plans, product portfolio, manufacturing and production capacity, global market position, financial status, and consumer base.

Key insights presented in the report:

  • Market revenue shares by major business players, by type, by application, and market scope of global Cancer Imaging Systems market
  • Sales revenue by key players and new entrants
  • Competitive analysis of the key players including aspects such as company overview, product or services specification, vendors, and buyers.
  • Recent mergers, acquisitions, product launches, recent investments, and joint ventures
  • Regional analysis to provide insight to recent trends and opportunities

The competitive analysis also includes regional analysis of major geographical regions. The report covers regions such as North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. The report also offers a country wise analysis to impart better understanding of the global Cancer Imaging Systems market with regards to market share, market size, production and consumption ratio, product launches and R&D activities, investment opportunities, and presence of key players in the region.

Get a sample of the report @ https://www.emergenresearch.com/request-sample/222

The report further segments the global Cancer Imaging Systems market on the basis of product types and applications and provides insights into key factors influencing the revenue growth of the segments.

  • Imaging Systems Outlook (Revenue, USD Billion; 2017-2027)

    • Mammography
    • Computed Tomography (CT)
    • Magnetic Resonance Imaging (MRI)
    • Ultrasound
    • Positron Emission Tomography (PET)
    • Others

  • Application Outlook (Revenue, USD Billion; 2017-2027)

    • Breast Cancer
    • Lung Cancer
    • Colorectal Cancer
    • Melanoma
    • Others

  • End-Users Outlook (Revenue, USD Billion; 2017-2027)

    • Hospitals & Clinics
    • Diagnostic Centers
    • Others

The report focuses on current and future market growth, technological advancements, volume, raw materials, and profiles of the key companies involved in the market. The report provides valuable insights to the stakeholders, investors, product managers, marketing executives, and other industry professionals.

Request customization of the report @ https://www.emergenresearch.com/request-for-customization/222

Thank you for reading our report. Please get in touch with us if you have any query regarding the report or its customization. Our team will ensure the report is best suited to your needs.

Browse More:

decentralized finance platforms market https://www.emergenresearch.com/industry-report/decentralized-finance-platforms-market 
Wireless Power Transmission Market https://www.emergenresearch.com/industry-report/wireless-power-transmission-market 
Certified Circular Plastics Market https://www.emergenresearch.com/industry-report/certified-circular-plastics-market 
Machine Vision Market https://www.emergenresearch.com/industry-report/machine-vision-market 
Transparent Display Market https://www.emergenresearch.com/industry-report/transparent-display-market